iLoF

Private

LondonHealthcare & Life Scienceshttps://ilof.tech/

Last Round

SAFE

Mar 9, 2026

Total Funding Raised

$12.67M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

iLoF is a digital health company with an AI and photonics platform that creates a digital library of biomarkers to accelerate personalized drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Clinical Trials, Medical AI, Precision Medicine, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts

AI Layer

Application

Keywords

biomarker discoverypatient stratificationclinical trial optimizationAI drug discoverydigital biomarkerspatient screeningprecision medicinephotonicsnon-invasive screeningoptical fingerprintsdrug development toolsmedical AIbiomarker libraryAlzheimer's diseaseneurodegenerative diseases

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iLoF Comps

Public and private peers based on sector, stage, and business model.

iLoF comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

iLoF Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
SAFE	Mar 9, 2026
Strategic	Oct 22, 2024
Grant	Jul 31, 2024
Accelerator	Jan 1, 2023
Seed	Jul 28, 2022
Grant	Jul 28, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Mehak Mumtaz

COO & Co-Founder

Founding Team

Bernardo Alba

Founders Senior Associate CEO Office

Founding Team

Luis Valente

CEO & Co-Founder

Founding Team

iLoF Investors

Notable investors and investment history

iLoF investors
Investor	Rounds
Hamamatsu Ventures	SAFE, Strategic
European Innovation Council	Accelerator
EIT Health	Accelerator
European Regional Development Fund	Grant
re.Mind Capital	Seed
M12 - Microsoft's Venture Fund	Seed, SAFE
EIT Health InnoStars Awards	SAFE

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 9, 2026
$231K raised from Hamamatsu Ventures, M12, and others.
Feb 19, 2026
Grew 30% QoQ, from 30 to 39 employees.

View all signals

iLoF Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

iLoF Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about iLoF's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Employee Range43

Year Founded2019

Last FundingMar 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.